Where Does AgeTech Investment Stand?: VCs Weigh Promise Against Payout

At Medicarians 2025, MedCity News Editor-in-Chief Arundhati Parmar explored the state of AgeTech venture capital with three investors. The panelists agreed that despite growing clear opportunities, the AgeTech market currently lacks the dedicated funding, proven business models and major success stories needed for it to take off. The post Where Does AgeTech Investment Stand?: VCs…

Read More

One Nation, Under Anxiety

Newscasts deliver reports of plane crashes, political turmoil, mass layoffs, rising food prices, and unexpected public health alerts at an increasing pace. In what used to be predictable routines – planning meals, commuting to work, taking kids to school – people across the country now sense an undercurrent of apprehension.  The post One Nation, Under…

Read More

Alzheon’s Precision Medicine Approach to Resurrect an Alzheimer’s Drug Fails Pivotal Study

Alzheon hoped testing its drug in a genetically defined subgroup of Alzheimer’s disease patients would succeed, overcoming earlier clinical trial failures. Instead, preliminary results show the pill failed to outdistance a placebo. The post Alzheon’s Precision Medicine Approach to Resurrect an Alzheimer’s Drug Fails Pivotal Study appeared first on MedCity News.

Read More